分析全组患者3年及5年总生存率(overall survival rates,OS)、局部控制率(local control rates,LC)和无病生存率(disease-free ...
基于36个网页-相关网页
GaseoyneRD等 州发现,BCL-2阳性患者,8年总生存率(OverallSurvival,OS)、无病生存率 (Disease—free Survival,DFS)和无复发生存(Relapse-f...
基于13个网页-相关网页
...床医学论文-论文联盟 观察指标 生存率:包括3年无瘤生存率(disease free survival, DFS)和3年总生存率(total survival rate, TSR)。 2.4 统计学分析 采用SPSS10.0统计 软件对数据进行x2检验。
基于4个网页-相关网页
在情况较差的病人组中,所有组的五年无病生存率以及估测十年总生存率在每个时间段内均相差不多,在84%到88%之间。
In the group with unfavorable features, 5-year event-free survival and estimates of 10-year overall survival were similar in all treatment groups and for each time period, ranging from 84% to 88%.
无论如何,除了90年代初期十分高龄的患者总的生存率还是都有所提高。
However, survival has improved in all but the very oldest ages since the early 1990s.
二级终点包含了目标反应率,一年生存期,总生存率,化疗类型和安全性PFS评估。
Secondary endpoints included objective response rate, one-year survival rate, overall survival, PFS assessment by chemotherapy type and safety.
应用推荐